OBTAINING RABIES VIRUS ANTIGEN AND ASSESSMENT OF ITS ACTIVITY AND SPECIFICITY IN IMMUNOSORBENT ASSAY AND IMMUNOBLOT

Author(s):  
A. G. Mukhamedzhanova ◽  
◽  
M. A. Efimova ◽  
A. N. Chernov ◽  
K. S. Khaertynov ◽  
...  
1995 ◽  
Vol 32 (3) ◽  
pp. 309-311 ◽  
Author(s):  
G. L. Foley ◽  
J. F. Zachary

A 1-year-old mixed breed heifer was presented to the Veterinary Medical Teaching Hospital at the University of Illinois with a 3-day history of abnormal mentation and aggressive behavior. Based on the history and clinical examination, euthanasia and necropsy were recommended. The differential diagnoses included rabies, pseudorabies, and a brain abscess. The brain was removed within 60 minutes of death, and the section submitted for fluorescent antibody testing was positive for rabies virus antigen. Residual brain tissue was immersion fixed in 10% neutral buffered formalin. Histologic examination revealed a marked perivascular and meningeal lymphocytic meningoencephalitis and locally extensive spongiform change of the gray matter affecting the neuropil and neuron cell bodies. The most severely affected regions with spongiform change were the thalamus and cerebral cortex. No Negri bodies were found in any sections. Since the outbreak of bovine spongiform encephalopathy (BSE) in the United Kingdom, there has been an increased surveillance of bovine neurologic cases in an effort to assess if BSE has occurred in the USA. In areas where rabies virus is endemic, rabies should be included as a possible differential diagnosis in cases of spongiform changes of the central nervous system.


2010 ◽  
Vol 17 (8) ◽  
pp. 1261-1268 ◽  
Author(s):  
Sridevi V. Nimmagadda ◽  
Shukra M. Aavula ◽  
Neelakantam Biradhar ◽  
Varaprasada Sankarasetty Rao ◽  
Rajalakshmi Shanmugham ◽  
...  

ABSTRACT The potency of rabies vaccines, determined using the NIH mouse protection test, can be directly correlated to the amount of rabies virus glycoprotein (RV GP) present in the vaccine. In an effort to develop a simple and sensitive enzyme-linked immunosorbent assay (ELISA) using recombinant diabody for quantification of RV GP, the variable heavy (VH) and light chain (VL) domains of an RV GP-specific human monoclonal antibody (MAb) secreted by a human × mouse heterohybridoma (human MAb R16E5) was amplified, linked using splicing by overlap extension PCR (SOE PCR), and expressed as a recombinant diabody (D06) in the pET28a bacterial expression system. The diabody D06 was purified by immobilized metal affinity chromatography on a nickel-nitrilotriacetic acid (NTA) agarose column and characterized. The purified diabody was used in combination with a well-characterized RV GP-specific mouse MAb, M5B4, to develop an immunocapture ELISA (IC-ELISA) for the quantification of RV GP in human rabies vaccine preparations. The maximum detection limit of the IC-ELISA using the M5B4-D06 combination was up to 31.25 ng/ml of RV GP. The specificity of the diabody was established by its nonreactivity toward other human viral antigens as determined by ELISA and toward RV GP as determined by immunoblot transfer assay and competitive ELISA with the parent human MAb R16E5 and MAb M5B4. The adjusted r 2 value obtained by the regression through the origin model was 0.902, and the equation for predicted potency values for M5B4-D06-based IC-ELISA and MAb M5B4 IC-ELISA were 0.5651x and 0.8044x, respectively, where x is the estimate of RV GP from the IC-ELISA in micrograms. Analysis of variance (ANOVA) results showed the estimates of the two methods differed significantly (P < 0.001), while the predicted potencies by the two tests did not differ significantly (P > 0.05). The IC-ELISA can be readily adapted to measure the RV GP content in purified antigen, and a vaccine can be formulated based on the estimated GP.


2011 ◽  
Vol 31 (2) ◽  
Author(s):  
A Garba ◽  
SI Oboegbulem ◽  
AU Junaidu ◽  
AA Magaji ◽  
JU Umoh ◽  
...  

2003 ◽  
Vol 32 (5) ◽  
pp. 545-550 ◽  
Author(s):  
G. Dhinakar Raj ◽  
S. Sivakumar ◽  
K. Matheswaran ◽  
M. Chandrasekhar ◽  
V. Thiagarajan ◽  
...  

2016 ◽  
Vol 237 ◽  
pp. 40-46 ◽  
Author(s):  
Taichi Shimatsu ◽  
Harumi Shinozaki ◽  
Kazunori Kimitsuki ◽  
Nozomi Shiwa ◽  
Daria L. Manalo ◽  
...  

1986 ◽  
Vol 32 (2) ◽  
pp. 189-192 ◽  
Author(s):  
R. Vincent Miller ◽  
Thomas W. Carroll ◽  
David C. Sands

A protocol was developed for testing chemical treatments for activity against seed-borne barley stripe mosaic virus. Vantage barley seeds infected with the MI-3 strain of the virus were allowed to imbibe dimethylsulfoxide solutions of test compounds. Of 49 compounds tested, alone or in combination with butylated hydroxyanisol, 18 reduced the number of plants expressing viral symptoms by up to 50%. Using an enzyme-linked immunosorbent assay to detect barley stripe mosaic virus, less than 2% of the asymptomatic plants arising from five chemical treatments were found to contain detectable virus antigen. In some treatments, reductions in the number of emerged plants with virus symptoms were correlated with reduced emergence.


Sign in / Sign up

Export Citation Format

Share Document